Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5181927
Max Phase: Preclinical
Molecular Formula: C14H12O4
Molecular Weight: 244.25
Associated Items:
ID: ALA5181927
Max Phase: Preclinical
Molecular Formula: C14H12O4
Molecular Weight: 244.25
Associated Items:
Canonical SMILES: O=C(O)Cc1ccc(O)cc1Oc1ccccc1
Standard InChI: InChI=1S/C14H12O4/c15-11-7-6-10(8-14(16)17)13(9-11)18-12-4-2-1-3-5-12/h1-7,9,15H,8H2,(H,16,17)
Standard InChI Key: CFSRLUGJCGONGU-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 244.25 | Molecular Weight (Monoisotopic): 244.0736 | AlogP: 2.81 | #Rotatable Bonds: 4 |
Polar Surface Area: 66.76 | Molecular Species: ACID | HBA: 3 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 3.71 | CX Basic pKa: | CX LogP: 2.81 | CX LogD: -0.50 |
Aromatic Rings: 2 | Heavy Atoms: 18 | QED Weighted: 0.87 | Np Likeness Score: 0.27 |
1. Tian Y, Shehata MA, Gauger SJ, Ng CKL, Solbak S, Thiesen L, Bruus-Jensen J, Krall J, Bundgaard C, Gibson KM, Wellendorph P, Frølund B.. (2022) Discovery and Optimization of 5-Hydroxy-Diclofenac toward a New Class of Ligands with Nanomolar Affinity for the CaMKIIα Hub Domain., 65 (9.0): [PMID:35500061] [10.1021/acs.jmedchem.1c02177] |
Source(1):